Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: A report of the ISPOR personalized medicine special interest group
Eric Faulkner, Lieven Annemans, Lou Garrison, Mark Helfand, Anke Peggy Holtorf, John Hornberger, Dyfrig Hughes, Tracy Li, Daniel Malone, Katherine Payne, Uwe Siebert, Adrian Towse, David Veenstra, John Watkins
Dive into the research topics of 'Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: A report of the ISPOR personalized medicine special interest group'. Together they form a unique fingerprint.